Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071473

Options or other derivatives

  • Chief Scientific Officer acquired 328,374 shares (grant or award)
  • Chief Scientific Officer returned 328,374 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hashim Mir Chief Scientific Officer 2023-12-16 Returned to the company · Stock Option (Right to Buy) −171,500 34,300 D: show line 1 in the form
Hashim Mir Chief Scientific Officer 2023-12-16 Grant or award · Stock Option (Right to Buy) +171,500 171,500 D: show line 2 in the form
Hashim Mir Chief Scientific Officer 2023-12-16 Returned to the company · Stock Option (Right to Buy) −73,150 52,250 D: show line 3 in the form
Hashim Mir Chief Scientific Officer 2023-12-16 Grant or award · Stock Option (Right to Buy) +73,150 73,150 D: show line 4 in the form
Hashim Mir Chief Scientific Officer 2023-12-16 Returned to the company · Stock Option (Right to Buy) −83,724 127,788 D: show line 5 in the form
Hashim Mir Chief Scientific Officer 2023-12-16 Grant or award · Stock Option (Right to Buy) +83,724 83,724 D: show line 6 in the form
Loading xslF345X05/ownership.xml…